Protein misfolding diseases therapeutics (Orphazyme)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameProtein misfolding diseases therapeutics (Orphazyme)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat-shock protein modulators
TargetsHeat-shock protein
Therapy Area/IndicationsGenetic Diseases, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrphazyme A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrphazyme A/S
Active IndicationsN/A
Inactive IndicationsGenetic Diseases, Inborn

Other Information

ATC CodeN/A
Related LinksN/A